- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Marksans Pharma acquired Netherlands-based QliniQ B.V. for €7.5 million, strengthening its European market presence with direct sales and distribution. QliniQ reported FY25 turnover of ~₹98.5 Cr and net profit of ~₹10.6 Cr, showcasing strong growth and a debt-free balance sheet.